Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,580,562
  • Shares Outstanding, K 384,396
  • Annual Sales, $ 6,848 M
  • Annual Income, $ -4,714 M
  • EBIT $ -4,635 M
  • EBITDA $ -4,075 M
  • 60-Month Beta 1.69
  • Price/Sales 3.07
  • Price/Cash Flow N/A
  • Price/Book 1.79

Options Overview Details

View History
  • Implied Volatility 84.84% ( +0.64%)
  • Historical Volatility 29.52%
  • IV Percentile 98%
  • IV Rank 91.29%
  • IV High 88.94% on 11/01/24
  • IV Low 41.88% on 05/17/24
  • Put/Call Vol Ratio 1.05
  • Today's Volume 1,696
  • Volume Avg (30-Day) 47,938
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 545,731
  • Open Int (30-Day) 533,132

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.91
  • Number of Estimates 12
  • High Estimate -0.98
  • Low Estimate -2.69
  • Prior Year -1.39
  • Growth Rate Est. (year over year) -37.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.26 +1.74%
on 10/24/24
60.65 -12.33%
on 10/07/24
-7.03 (-11.68%)
since 10/04/24
3-Month
52.26 +1.74%
on 10/24/24
91.99 -42.20%
on 08/19/24
-30.58 (-36.51%)
since 08/05/24
52-Week
52.26 +1.74%
on 10/24/24
170.47 -68.81%
on 05/24/24
-24.36 (-31.42%)
since 11/03/23

Most Recent Stories

More News
Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?

Moderna MRNA is set to report third-quarter 2024 earnings on Nov. 7, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $1.25 billion and a loss of $1.91 per share,...

MRK : 100.75 (-1.10%)
MRNA : 53.20 (-0.64%)
GSK : 36.50 (-1.27%)
PFE : 27.75 (-0.04%)
Option Volatility And Earnings Report For November 4 - 8

We have some important companies with Palantir, Super Micro computer, Block, Moderna, Qualcomm, Arista Networks, Gilead Sciences and Airbnb all set to report.

QCOM : 166.71 (+0.93%)
GILD : 89.69 (-0.17%)
FSLY : 7.23 (+1.97%)
MRNA : 53.20 (-0.64%)
AMZN : 196.88 (+0.56%)
PLTR : 50.52 (+22.00%)
BMY : 55.22 (-0.41%)
ANET : 405.06 (+2.58%)
AAPL : 223.50 (+0.67%)
SMCI : 25.48 (-2.11%)
MSTR : 237.43 (+6.48%)
ABNB : 140.03 (+2.31%)
2 Dividend Stocks to Buy for a Lifetime of Passive Income

These are the kinds of stocks that can allow investors to sleep easy at night.

MRK : 100.75 (-1.10%)
SMMT : 19.90 (-0.30%)
MDT : 89.05 (-0.29%)
MRNA : 53.20 (-0.64%)
ISRG : 515.90 (+1.67%)
Stocks Close Higher on Reduced Middle East Risks

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.68%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.12%. Stocks rallied...

UAL : 78.20 (+1.23%)
AAPL : 223.50 (+0.67%)
CVX : 154.19 (+0.14%)
MRO : 27.66 (+0.55%)
ABNB : 140.03 (+2.31%)
$IUXX : 20,171.77 (+1.04%)
COIN : 192.71 (+3.46%)
ZNZ24 : 110-000 (-0.33%)
OXY : 50.52 (-0.08%)
FANG : 176.35 (-1.90%)
SBUX : 97.08 (+0.05%)
$DOWI : 42,040.35 (+0.59%)
Stocks Higher on Relief After Israel's Limited Retaliation Reduces Middle East Risks

The S&P 500 Index ($SPX ) (SPY ) is up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. Stocks today are trading higher on reduced...

UAL : 78.20 (+1.23%)
AAPL : 223.50 (+0.67%)
CVX : 154.19 (+0.14%)
MRO : 27.66 (+0.55%)
ABNB : 140.03 (+2.31%)
$IUXX : 20,171.77 (+1.04%)
COIN : 192.71 (+3.46%)
ZNZ24 : 110-000 (-0.33%)
OXY : 50.52 (-0.08%)
TSLA : 251.44 (+3.54%)
FANG : 176.35 (-1.90%)
SBUX : 97.08 (+0.05%)
Earnings Preview: What to Expect From Moderna's Report

Moderna is all set to release its fiscal third-quarter earnings next month, and analysts project its loss to rise in double digits.

XLV : 146.90 (+0.09%)
$SPX : 5,757.65 (+0.79%)
MRNA : 53.20 (-0.64%)
How Bad Is This News for Novavax?

Novavax stock fell 20% in one trading session on the news.

NVAX : 9.20 (+0.88%)
MRNA : 53.20 (-0.64%)
Moderna Stock Falls 20% in a Month: Time to Sell or Hold?

Despite giving the world one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have lost significantly in the past couple of years due to declining sales amid low demand for the...

MRNA : 53.20 (-0.64%)
GSK : 36.50 (-1.27%)
PFE : 27.75 (-0.04%)
2 Biotech Stocks That Are Screaming Buys This Month

They won't remain southbound forever.

CRSP : 47.43 (-6.25%)
MRNA : 53.20 (-0.64%)
GSK Posts New Data From Phase III Study on RSV Vaccine Arexvy

GSK plc GSK announced new data from the phase III AReSVi-006 (Adult Respiratory Syncytial Virus) study. The study evaluated the efficacy of a single dose of its respiratory syncytial virus (RSV) vaccine,...

MRNA : 53.20 (-0.64%)
GSK : 36.50 (-1.27%)
PFE : 27.75 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 57.23
2nd Resistance Point 56.44
1st Resistance Point 54.99
Last Price 53.20
1st Support Level 52.75
2nd Support Level 51.96
3rd Support Level 50.51

See More

52-Week High 170.47
Fibonacci 61.8% 125.31
Fibonacci 50% 111.36
Fibonacci 38.2% 97.42
Last Price 53.20
52-Week Low 52.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar